dacarbazine and sb 203580

dacarbazine has been researched along with sb 203580 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, MS; Haas-Kogan, DA; Hirose, Y; Katayama, M; Pieper, RO; Stokoe, D	1
Gu, Y; Liu, J; Ma, L; Qi, J; Yu, W; Zhang, X	1

Other Studies

2 other study(ies) available for dacarbazine and sb 203580

Article	Year
The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Molecular and cellular biology, 2003, Volume: 23, Issue:22 Topics: Antineoplastic Agents, Alkylating; Base Pair Mismatch; Base Sequence; Cell Line, Tumor; Dacarbazine; DNA Methylation; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; G2 Phase; Humans; Imidazoles; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; Temozolomide	2003
p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ. Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:3 Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Glioma; Heme Oxygenase-1; Humans; Imidazoles; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Temozolomide	2015

Article

Year

The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents.

Molecular and cellular biology, 2003, Volume: 23, Issue:22

Topics: Antineoplastic Agents, Alkylating; Base Pair Mismatch; Base Sequence; Cell Line, Tumor; Dacarbazine; DNA Methylation; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; G2 Phase; Humans; Imidazoles; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; Temozolomide

2003

p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ.

Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:3

Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Glioma; Heme Oxygenase-1; Humans; Imidazoles; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Temozolomide

2015